Suppr超能文献

粒细胞集落刺激因子(G-CSF)的使用对辅助生殖技术后的结局是否有有益影响?一项系统评价和荟萃分析。

Whether G-CSF administration has beneficial effect on the outcome after assisted reproductive technology? A systematic review and meta-analysis.

作者信息

Zhao J, Xu B, Xie S, Zhang Q, Li Y P

机构信息

Department of Reproductive Medicine, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha City, Hunan Province, 410008, People's Republic of China.

出版信息

Reprod Biol Endocrinol. 2016 Sep 22;14(1):62. doi: 10.1186/s12958-016-0197-2.

Abstract

BACKGROUND

Previous studies have explored the effect of granulocyte colony stimulating factor (G-CSF) administration on the outcome of assisted reproductive technology (ART), and came into controversial conclusions. The present meta-analysis aims to assess whether G-CSF administration has beneficial effect on the outcome after ART.

METHOD

The electronic databases Pubmed, Embase and Google Scholar were searched up to May 2016. Articles that studied the effect of G-CSF administration on the outcome after ART were included in the present meta-analysis. Odds ratio (OR) with 95 % confidence interval (95 % CI) were calculated to assess the effect of G-CSF administration on the outcome after ART. The outcomes of interest were implantation rate (IR) and pregnancy rate (PR).

RESULTS

Four cohort studies with 1101 embryos transplantation assessed the effect of G-CSF administration on IR and 6 studies with 621 cycles assessed the role of G-CSF administration in PR. Meta-analysis did not found an increased embryo IR in G-CSF administration cycles [OR 1.59 (95 % CI 0.74-3.41). whereas the PR with G-CSF administration was significantly higher compared with cases without G-CSF administration [OR 2.03 (95 % CI 1.19-3.46)]. Additionally, we found that G-CSF administrated subcutaneously resulted in significantly higher PR [OR 3.12 (95 % CI 1.67-5.81)] and IR [OR 2.82 (95 % CI 1.29-6.15)] compared with control group, whereas G-CSF administrated via local uterine infusion had no beneficial effect on the PR [OR 1.42 (95 % CI 0.91-2.24)] and IR [OR 1.10 (95 % CI 0.76-1.60)] after ART.

CONCLUSIONS

G-CSF administration may have beneficial effect on clinical pregnancy outcome after ART. Subcutaneous injection may be an optimal route of G-CSF administration. Further cohort studies are required to explore the mechanisms undergone the effect and investigate the best route and dose of G-CSF administration.

摘要

背景

既往研究探讨了粒细胞集落刺激因子(G-CSF)给药对辅助生殖技术(ART)结局的影响,但得出了相互矛盾的结论。本荟萃分析旨在评估G-CSF给药对ART后结局是否具有有益作用。

方法

检索截至2016年5月的电子数据库PubMed、Embase和谷歌学术。本荟萃分析纳入了研究G-CSF给药对ART后结局影响的文章。计算比值比(OR)及其95%置信区间(95%CI),以评估G-CSF给药对ART后结局的影响。感兴趣的结局指标为着床率(IR)和妊娠率(PR)。

结果

四项涉及1101例胚胎移植的队列研究评估了G-CSF给药对IR的影响,六项涉及621个周期的研究评估了G-CSF给药在PR中的作用。荟萃分析未发现G-CSF给药周期的胚胎IR增加[OR 1.59(95%CI 0.74 - 3.41)],而与未给予G-CSF的病例相比,给予G-CSF的PR显著更高[OR 2.03(95%CI 1.19 - 3.46)]。此外,我们发现与对照组相比,皮下注射G-CSF导致PR[OR 3.12(95%CI 1.67 - 5.81)]和IR[OR 2.82(95%CI 1.29 - 6.15)]显著更高,而ART后经局部子宫灌注给予G-CSF对PR[OR 1.42(95%CI 0.91 - 2.24)]和IR[OR 1.10(95%CI 0.76 - 1.60)]没有有益作用。

结论

G-CSF给药可能对ART后的临床妊娠结局具有有益作用。皮下注射可能是G-CSF给药的最佳途径。需要进一步的队列研究来探讨其作用机制,并研究G-CSF给药的最佳途径和剂量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f959/5034435/7d970523f721/12958_2016_197_Fig1_HTML.jpg

相似文献

4
Use of granulocyte-colony stimulating factor in assisted reproductive technology: A systematic review and meta-analysis.
Eur J Obstet Gynecol Reprod Biol. 2017 Jul;214:16-24. doi: 10.1016/j.ejogrb.2017.04.022. Epub 2017 Apr 13.
5
Treatment of G-CSF in unexplained, repeated implantation failure: A systematic review and meta-analysis.
J Gynecol Obstet Hum Reprod. 2020 Jul 11:101866. doi: 10.1016/j.jogoh.2020.101866.

引用本文的文献

1
Network meta-analysis on the efficacy of different interventions for treating thin endometrium.
Front Endocrinol (Lausanne). 2025 Aug 20;16:1575248. doi: 10.3389/fendo.2025.1575248. eCollection 2025.
2
The Mechanisms and therapeutic effects of granulocyte colony-stimulating factor in reproduction.
Reprod Biol Endocrinol. 2025 May 26;23(1):78. doi: 10.1186/s12958-025-01414-y.
7
TJZYF Improves Endometrial Receptivity through Regulating VEGF and PI3K/AKT Signaling Pathway.
Biomed Res Int. 2022 Sep 23;2022:9212561. doi: 10.1155/2022/9212561. eCollection 2022.
8
Efficacy of subcutaneous granulocyte colonystimulating factor infusion for treating thin endometrium.
Clin Exp Reprod Med. 2022 Mar;49(1):70-73. doi: 10.5653/cerm.2021.04833. Epub 2022 Feb 28.
9
Approaches to Improve Endometrial Receptivity in Case of Repeated Implantation Failures.
Front Cell Dev Biol. 2021 Mar 16;9:613277. doi: 10.3389/fcell.2021.613277. eCollection 2021.
10
CXCL12 enhances pregnancy outcome via improvement of endometrial receptivity in mice.
Sci Rep. 2021 Apr 1;11(1):7397. doi: 10.1038/s41598-021-86956-y.

本文引用的文献

1
Granulocyte colony-stimulating factor in repeated IVF failure, a randomized trial.
Reproduction. 2016 Jun;151(6):637-42. doi: 10.1530/REP-16-0046. Epub 2016 Mar 15.
2
Two protocols to treat thin endometrium with granulocyte colony-stimulating factor during frozen embryo transfer cycles.
Reprod Biomed Online. 2015 Apr;30(4):349-58. doi: 10.1016/j.rbmo.2014.12.006. Epub 2014 Dec 30.
4
Granulocyte-Colony Stimulating Factor related pathways tested on an endometrial ex-vivo model.
PLoS One. 2014 Oct 2;9(9):e102286. doi: 10.1371/journal.pone.0102286. eCollection 2014.
5
Endometrial pattern, thickness and growth in predicting pregnancy outcome following 3319 IVF cycle.
Reprod Biomed Online. 2014 Sep;29(3):291-8. doi: 10.1016/j.rbmo.2014.05.011. Epub 2014 Jun 13.
7
Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis.
Hum Reprod Update. 2014 Jul-Aug;20(4):530-41. doi: 10.1093/humupd/dmu011. Epub 2014 Mar 23.
10
Impact of follicular G-CSF quantification on subsequent embryo transfer decisions: a proof of concept study.
Hum Reprod. 2013 Feb;28(2):406-13. doi: 10.1093/humrep/des354. Epub 2012 Dec 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验